General Information of Drug Off-Target (DOT) (ID: OTTQ468O)

DOT Name Intestinal-type alkaline phosphatase (ALPI)
Synonyms IAP; Intestinal alkaline phosphatase; EC 3.1.3.1
Gene Name ALPI
UniProt ID
PPBI_HUMAN
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
EC Number
3.1.3.1
Pfam ID
PF00245
Sequence
MQGPWVLLLLGLRLQLSLGVIPAEEENPAFWNRQAAEALDAAKKLQPIQKVAKNLILFLG
DGLGVPTVTATRILKGQKNGKLGPETPLAMDRFPYLALSKTYNVDRQVPDSAATATAYLC
GVKANFQTIGLSAAARFNQCNTTRGNEVISVMNRAKQAGKSVGVVTTTRVQHASPAGTYA
HTVNRNWYSDADMPASARQEGCQDIATQLISNMDIDVILGGGRKYMFPMGTPDPEYPADA
SQNGIRLDGKNLVQEWLAKHQGAWYVWNRTELMQASLDQSVTHLMGLFEPGDTKYEIHRD
PTLDPSLMEMTEAALRLLSRNPRGFYLFVEGGRIDHGHHEGVAYQALTEAVMFDDAIERA
GQLTSEEDTLTLVTADHSHVFSFGGYTLRGSSIFGLAPSKAQDSKAYTSILYGNGPGYVF
NSGVRPDVNESESGSPDYQQQAAVPLSSETHGGEDVAVFARGPQAHLVHGVQEQSFVAHV
MAFAACLEPYTACDLAPPACTTDAAHPVAASLPLLAGTLLLLGASAAP
Function Alkaline phosphatase that can hydrolyze various phosphate compounds.
KEGG Pathway
Thiamine metabolism (hsa00730 )
Folate biosynthesis (hsa00790 )
Metabolic pathways (hsa01100 )
Biosynthesis of cofactors (hsa01240 )
Reactome Pathway
Post-translational modification (R-HSA-163125 )
Digestion (R-HSA-8935690 )
Synthesis of PA (R-HSA-1483166 )

Molecular Interaction Atlas (MIA) of This DOT

Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This DOT
3 Drug(s) Affected the Post-Translational Modifications of This DOT
Drug Name Drug ID Highest Status Interaction REF
Valproate DMCFE9I Approved Valproate increases the methylation of Intestinal-type alkaline phosphatase (ALPI). [1]
Bisphenol A DM2ZLD7 Investigative Bisphenol A increases the methylation of Intestinal-type alkaline phosphatase (ALPI). [5]
Coumarin DM0N8ZM Investigative Coumarin decreases the phosphorylation of Intestinal-type alkaline phosphatase (ALPI). [7]
------------------------------------------------------------------------------------
11 Drug(s) Affected the Gene/Protein Processing of This DOT
Drug Name Drug ID Highest Status Interaction REF
Estradiol DMUNTE3 Approved Estradiol increases the expression of Intestinal-type alkaline phosphatase (ALPI). [2]
Methotrexate DM2TEOL Approved Methotrexate increases the activity of Intestinal-type alkaline phosphatase (ALPI). [3]
Genistein DM0JETC Phase 2/3 Genistein increases the expression of Intestinal-type alkaline phosphatase (ALPI). [2]
Benzo(a)pyrene DMN7J43 Phase 1 Benzo(a)pyrene decreases the expression of Intestinal-type alkaline phosphatase (ALPI). [4]
Wortmannin DM8EVK5 Terminated Wortmannin increases the activity of Intestinal-type alkaline phosphatase (ALPI). [3]
Formaldehyde DM7Q6M0 Investigative Formaldehyde decreases the expression of Intestinal-type alkaline phosphatase (ALPI). [6]
Sulforaphane DMQY3L0 Investigative Sulforaphane decreases the expression of Intestinal-type alkaline phosphatase (ALPI). [8]
KOJIC ACID DMP84CS Investigative KOJIC ACID decreases the expression of Intestinal-type alkaline phosphatase (ALPI). [9]
Cycloheximide DMGDA3C Investigative Cycloheximide decreases the activity of Intestinal-type alkaline phosphatase (ALPI). [10]
Microcystin-LR DMTMLRN Investigative Microcystin-LR decreases the expression of Intestinal-type alkaline phosphatase (ALPI). [11]
PD98059 DMZC90M Investigative PD98059 increases the activity of Intestinal-type alkaline phosphatase (ALPI). [3]
------------------------------------------------------------------------------------
⏷ Show the Full List of 11 Drug(s)

References

1 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
2 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
3 Methotrexate induced differentiation in colon cancer cells is primarily due to purine deprivation. J Cell Biochem. 2006 Sep 1;99(1):146-55. doi: 10.1002/jcb.20908.
4 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
5 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
6 Cellular reactions to long-term volatile organic compound (VOC) exposures. Sci Rep. 2016 Dec 1;6:37842. doi: 10.1038/srep37842.
7 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
8 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
9 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.
10 Deoxynivalenol affects in vitro intestinal epithelial cell barrier integrity through inhibition of protein synthesis. Toxicol Appl Pharmacol. 2010 Jun 15;245(3):291-8. doi: 10.1016/j.taap.2010.03.012. Epub 2010 Apr 1.
11 Gene expression network regulated by DNA methylation and microRNA during microcystin-leucine arginine induced malignant transformation in human hepatocyte L02 cells. Toxicol Lett. 2018 Jun 1;289:42-53. doi: 10.1016/j.toxlet.2018.03.003. Epub 2018 Mar 5.